Public SEC Form D records
Biotech Series B Form D filings - July 2026
This page lists the 7 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series B stage in July 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 7
- Issuers
- 7
- Combined disclosed
- $181.1M
Directory links
Filing records
7 crawlable filing links in this facet.
- Enumera Molecular, Inc.July 31, 2026 / Reg D 506(b) / MI$17.4M
- NextPoint Therapeutics, Inc.July 30, 2026 / Reg D 506(b) / MA$48.7M
- Dash Bio, Inc.July 14, 2026 / Reg D 506(b) / MA$30.0M
- Amlogenyx Inc.July 9, 2026 / Reg D 506(b) / CA$20.0M
- Chronicle Bio, Inc.July 7, 2026 / Reg D 506(b) / CA$15.0M
- Myrtelle Inc.July 2, 2026 / Reg D 506(b) / NY$30.0M
- Lungpacer Medical, Inc.July 2, 2026 / Reg D 506(b) / PA$20.0M